MAXIMUS, Inc. (NYSE:MMS) Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. reduced its stake in shares of MAXIMUS, Inc. (NYSE:MMS) by 9.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,853 shares of the health services provider’s stock after selling 973 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in MAXIMUS were worth $642,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of MAXIMUS during the first quarter worth about $23,766,000. DekaBank Deutsche Girozentrale raised its position in shares of MAXIMUS by 234.8% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 409,159 shares of the health services provider’s stock valued at $29,558,000 after purchasing an additional 286,959 shares in the last quarter. William Blair Investment Management LLC raised its position in shares of MAXIMUS by 1,370.8% in the 1st quarter. William Blair Investment Management LLC now owns 250,952 shares of the health services provider’s stock valued at $17,813,000 after purchasing an additional 233,890 shares in the last quarter. Skandinaviska Enskilda Banken AB publ boosted its stake in shares of MAXIMUS by 18.8% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 1,137,027 shares of the health services provider’s stock valued at $82,480,000 after buying an additional 179,581 shares during the last quarter. Finally, Glassman Wealth Services purchased a new position in shares of MAXIMUS during the 1st quarter valued at approximately $10,575,000. Institutional investors and hedge funds own 94.88% of the company’s stock.

In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $72.90, for a total value of $72,900.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 35,000 shares of MAXIMUS stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $74.68, for a total value of $2,613,800.00. Following the completion of the transaction, the insider now owns 377,874 shares of the company’s stock, valued at $28,219,630.32. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

A number of analysts have recently weighed in on MMS shares. Canaccord Genuity lifted their price target on shares of MAXIMUS from $72.00 to $77.00 and gave the stock a “hold” rating in a research note on Tuesday, August 13th. Wells Fargo & Co reiterated a “market perform” rating and set a $83.00 price objective on shares of MAXIMUS in a research note on Friday, August 9th. ValuEngine downgraded shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Friday, June 28th. Finally, Zacks Investment Research raised shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a report on Monday, May 27th.

NYSE:MMS traded up $0.33 during mid-day trading on Wednesday, reaching $78.80. The stock had a trading volume of 7,991 shares, compared to its average volume of 270,260. The company has a market capitalization of $5.03 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 2.11 and a beta of 0.88. MAXIMUS, Inc. has a 1-year low of $60.00 and a 1-year high of $80.83. The stock’s 50 day simple moving average is $75.78 and its two-hundred day simple moving average is $73.18.

MAXIMUS (NYSE:MMS) last issued its earnings results on Thursday, August 8th. The health services provider reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. The company had revenue of $730.70 million during the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The business’s revenue was up 22.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. As a group, analysts predict that MAXIMUS, Inc. will post 3.73 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Thursday, August 15th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date was Wednesday, August 14th. MAXIMUS’s dividend payout ratio is presently 29.41%.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

See Also: What does a neutral rating on stocks mean?

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.